Torcetrapib effect on adrenal carcinoma cell line - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS3556

Torcetrapib effect on adrenal carcinoma cell line

Analysis of H295 adrenal carcinoma cells treated with torcetrapib, an anti-cholesterol drug. Adverse side effects of torcetrapib treatment include changes in blood pressure, potassium, sodium, and aldosterone. Results provide insight into the molecular basis of the off-target side effects.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 3 agent sets

Platform:: GPL570
Series:: GSE15918
9 Samples

Download data: CEL

DataSet

Accession:: GDS3556

ID:: 3556

PubMed Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Torcetrapib effect on adrenal carcinoma cell line
Torcetrapib effect on adrenal carcinoma cell line
Accession: GDS3556

GEO DataSets
Related DataSets for GEO Profiles (Select 60736145) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets